| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,069 |
20,350 |
$1.58M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,592 |
6,023 |
$567K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,644 |
3,404 |
$335K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,335 |
4,823 |
$267K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,922 |
2,767 |
$261K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,147 |
2,474 |
$252K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,872 |
1,799 |
$161K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,854 |
7,978 |
$119K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,319 |
2,943 |
$64K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
312 |
277 |
$41K |
| 92552 |
|
5,642 |
5,337 |
$39K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
766 |
699 |
$38K |
| 99050 |
|
5,731 |
4,613 |
$30K |
| 99215 |
Prolong outpt/office vis |
216 |
201 |
$26K |
| 99188 |
|
4,715 |
4,298 |
$25K |
| 99381 |
|
382 |
286 |
$20K |
| 94010 |
|
3,148 |
2,963 |
$19K |
| 97802 |
|
4,704 |
3,728 |
$19K |
| 99383 |
|
158 |
152 |
$13K |
| 90680 |
|
1,256 |
1,117 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,763 |
3,323 |
$10K |
| 99058 |
|
338 |
245 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,322 |
979 |
$6K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
117 |
107 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
889 |
688 |
$5K |
| 90670 |
|
1,848 |
1,652 |
$5K |
| 87631 |
|
441 |
389 |
$5K |
| 87807 |
|
1,451 |
1,261 |
$4K |
| 99384 |
|
53 |
43 |
$4K |
| 99382 |
|
43 |
40 |
$4K |
| 83655 |
|
1,436 |
1,368 |
$4K |
| 90707 |
|
737 |
660 |
$3K |
| 90461 |
|
2,328 |
2,057 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
53 |
$3K |
| 81003 |
|
4,187 |
3,664 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
755 |
663 |
$3K |
| 90473 |
|
619 |
591 |
$2K |
| 90734 |
|
694 |
617 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
940 |
671 |
$2K |
| 94664 |
|
778 |
660 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,960 |
3,033 |
$2K |
| 99401 |
|
539 |
465 |
$1K |
| 85018 |
|
1,439 |
1,364 |
$970.66 |
| 81025 |
|
400 |
359 |
$946.17 |
| 90651 |
|
752 |
690 |
$907.65 |
| 0001A |
|
74 |
72 |
$838.11 |
| 90715 |
|
623 |
550 |
$720.27 |
| 0072A |
|
44 |
27 |
$720.00 |
| 90716 |
|
737 |
662 |
$719.90 |
| 90686 |
|
994 |
948 |
$695.37 |
| 87428 |
|
30 |
30 |
$693.33 |
| 0002A |
|
63 |
63 |
$676.21 |
| 90688 |
|
548 |
488 |
$612.11 |
| 81000 |
|
966 |
843 |
$576.91 |
| 99442 |
|
42 |
22 |
$552.47 |
| 0071A |
|
33 |
21 |
$520.00 |
| 90710 |
|
98 |
72 |
$445.84 |
| 81002 |
|
769 |
665 |
$418.00 |
| 90698 |
|
759 |
645 |
$384.69 |
| 90672 |
|
654 |
623 |
$373.73 |
| 87634 |
|
70 |
64 |
$312.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
85 |
83 |
$233.32 |
| 92587 |
|
59 |
39 |
$231.53 |
| 92015 |
Determination of refractive state |
42 |
30 |
$191.91 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
72 |
57 |
$182.49 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
109 |
90 |
$160.64 |
| 96127 |
|
332 |
306 |
$157.93 |
| S9451 |
Exercise classes, non-physician provider, per session |
2,074 |
1,573 |
$125.08 |
| 90648 |
|
922 |
845 |
$90.26 |
| 92551 |
|
188 |
178 |
$89.89 |
| 90713 |
|
747 |
710 |
$89.02 |
| 96156 |
|
114 |
102 |
$80.94 |
| 91300 |
|
161 |
143 |
$78.89 |
| 90687 |
|
194 |
145 |
$72.84 |
| 99174 |
|
116 |
109 |
$68.02 |
| 99177 |
|
29 |
27 |
$54.01 |
| 90700 |
|
1,222 |
1,136 |
$45.80 |
| 99173 |
|
91 |
84 |
$35.50 |
| 90633 |
|
1,171 |
1,028 |
$32.03 |
| 96136 |
|
12 |
12 |
$30.72 |
| 99051 |
|
14 |
14 |
$30.28 |
| 94760 |
|
1,747 |
1,312 |
$28.75 |
| 90744 |
|
900 |
782 |
$20.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,063 |
824 |
$16.56 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
13 |
12 |
$8.02 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
17 |
12 |
$0.26 |
| 3008F |
|
4,514 |
3,533 |
$0.00 |
| 1005F |
|
431 |
396 |
$0.00 |
| 1111F |
|
205 |
159 |
$0.00 |
| 1038F |
|
207 |
197 |
$0.00 |
| D1330 |
|
570 |
540 |
$0.00 |
| 91307 |
|
172 |
82 |
$0.00 |
| 2016F |
|
45 |
42 |
$0.00 |
| 2015F |
|
45 |
42 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
41 |
41 |
$0.00 |
| 90620 |
|
19 |
17 |
$0.00 |
| 36416 |
|
52 |
47 |
$0.00 |
| D1310 |
|
69 |
67 |
$0.00 |
| 2014F |
|
331 |
301 |
$0.00 |
| 4120F |
|
169 |
147 |
$0.00 |
| 3023F |
|
491 |
472 |
$0.00 |
| 3210F |
|
906 |
787 |
$0.00 |
| 4124F |
|
544 |
479 |
$0.00 |
| 99499 |
|
21 |
21 |
$0.00 |
| 1116F |
|
42 |
32 |
$0.00 |